Knockdown of TRB3 improved the MPP+/MPTP-induced Parkinson's disease through the MAPK and AKT signaling pathways

被引:9
作者
Hu, Fei [1 ]
Duan, Mingyue [1 ]
Peng, Niancai [1 ,2 ]
机构
[1] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710054, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, State Minist Educ, Biomedinformat Engn Lab, Xian 710049, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
TRB3; Parkinson's disease; MAPK; AKT; ATF4/CHOP; OXIDATIVE STRESS; TRIBBLES HOMOLOG; APOPTOSIS; ACTIVATION; INSULIN; PSEUDOKINASE; PATHOGENESIS; NEPHROPATHY; AUTOPHAGY; CYTOKINE;
D O I
10.1016/j.neulet.2019.134352
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study aims to investigate the function and molecular mechanisms of Tribbles homolog 3 (TRB3) on the MPP+/MPTP-induced Parkinson's disease (PD). In this study, MPP+-induced PD cellular model and MPTP-caused PD mice model were established. Following the transfection with TRB3-shRNA, cell viability, cell apoptosis, ROS level, and the ratio of p-p38/ p38, p-JNK/JNK, p-AKT/AKT were examined. At the same time, behavior assessment of wild type female C57BL/6 mice and whole-body TRB3 knockout mice PD models caused by MPTP were performed by Rotarod test and Open-field test. The results showed that TRB3 was markedly upregulated in MPP+-induced cellular model through ATF4/CHOP pathway. Knockdown of TRB3 significantly decreased the MPP+-induced reduction of cell viability, augment of cell apoptosis and accumulation of ROS, inhibited the phosphorylation of p38 and JNK, and promoted the phosphorylation of AKT, in vitro. Further, knockout of TRB3 improved the behavior impairment of PD mice induced by MPTP, in vivo. In conclusion, knockdown of TRB3 has a neuroprotective effect on MPTP/MPP+-induced PD cellular and mice models, through regulating MAPK and AKT signaling pathways.
引用
收藏
页数:8
相关论文
共 44 条
[1]   Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models [J].
Aime, Pascaline ;
Sun, Xiaotian ;
Zareen, Neela ;
Rao, Apeksha ;
Berman, Zachary ;
Volpicelli-Daley, Laura ;
Bernd, Paulette ;
Crary, John F. ;
Levy, Oren A. ;
Greene, Lloyd A. .
JOURNAL OF NEUROSCIENCE, 2015, 35 (30) :10731-10749
[2]   Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra [J].
Alam, ZI ;
Jenner, A ;
Daniel, SE ;
Lees, AJ ;
Cairns, N ;
Marsden, CD ;
Jenner, P ;
Halliwell, B .
JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) :1196-1203
[3]   Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease [J].
AlDakheel, Amaal ;
Kalia, Lorraine V. ;
Lang, Anthony E. .
NEUROTHERAPEUTICS, 2014, 11 (01) :6-23
[4]  
[Anonymous], WORLD CHINESE J DIG
[5]  
[Anonymous], ONCOTARGET
[6]  
[Anonymous], SOURCES REACTIVE OXY
[7]  
[Anonymous], ANTITUMOR PHARM
[8]  
[Anonymous], 2015, BMC RES NOTES
[9]  
[Anonymous], 2009, AM J ENDOCRINOL META, DOI DOI 10.1152/ajpendo.00467.2009
[10]   Amino Acid Availability Controls TRB3 Transcription in Liver through the GCN2/eIF2α/ATF4 Pathway [J].
Carraro, Valerie ;
Maurin, Anne-Catherine ;
Lambert-Langlais, Sarah ;
Averous, Julien ;
Chaveroux, Cedric ;
Parry, Laurent ;
Jousse, Celine ;
Oerd, Daima ;
Oerd, Tonis ;
Fafournoux, Pierre ;
Bruhat, Alain .
PLOS ONE, 2010, 5 (12)